1. Home
  2. COEP vs ANEB Comparison

COEP vs ANEB Comparison

Compare COEP & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • ANEB
  • Stock Information
  • Founded
  • COEP 2017
  • ANEB 2020
  • Country
  • COEP United States
  • ANEB United States
  • Employees
  • COEP N/A
  • ANEB N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • COEP Health Care
  • ANEB Health Care
  • Exchange
  • COEP Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • COEP 32.4M
  • ANEB 36.7M
  • IPO Year
  • COEP N/A
  • ANEB 2021
  • Fundamental
  • Price
  • COEP $12.31
  • ANEB $1.44
  • Analyst Decision
  • COEP
  • ANEB Buy
  • Analyst Count
  • COEP 0
  • ANEB 1
  • Target Price
  • COEP N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • COEP 121.3K
  • ANEB 12.2K
  • Earning Date
  • COEP 03-25-2025
  • ANEB 02-21-2025
  • Dividend Yield
  • COEP N/A
  • ANEB N/A
  • EPS Growth
  • COEP N/A
  • ANEB N/A
  • EPS
  • COEP N/A
  • ANEB N/A
  • Revenue
  • COEP N/A
  • ANEB N/A
  • Revenue This Year
  • COEP N/A
  • ANEB N/A
  • Revenue Next Year
  • COEP N/A
  • ANEB N/A
  • P/E Ratio
  • COEP N/A
  • ANEB N/A
  • Revenue Growth
  • COEP N/A
  • ANEB N/A
  • 52 Week Low
  • COEP $2.31
  • ANEB $0.80
  • 52 Week High
  • COEP $13.70
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • COEP 62.60
  • ANEB 42.68
  • Support Level
  • COEP $8.65
  • ANEB $1.45
  • Resistance Level
  • COEP $13.70
  • ANEB $1.61
  • Average True Range (ATR)
  • COEP 1.89
  • ANEB 0.13
  • MACD
  • COEP -0.21
  • ANEB -0.02
  • Stochastic Oscillator
  • COEP 72.48
  • ANEB 13.93

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: